Renaissance Capital logo

PHAT News

US IPO Week Ahead: Another quiet week for the IPO market with 1 biotech

WIMI

Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for...read more

US IPO Weekly Recap: IPO market serves up tricks and treats in diverse 8-IPO week

ONEW

In the busiest week since July, eight companies entered the public market while recreational boat retailer OneWater Marine (ONEW) postponed its $60 million deal. Two insurance plays and a biotech traded up more than 15%, while ...read more

PHAT IPO gets bigger: Phathom Pharmaceuticals prices upsized IPO at $19 midpoint

Phathom Pharmaceuticals logo

Phathom Pharmaceuticals, a Phase 3 biotech developing novel therapies for gastrointestinal diseases, raised $182 million by offering 9.6 million shares at $19, the midpoint of the $18 to $20 range. The company upsized its offering by 21%. Phathom Pharmaceuticals...read more

US IPO Week Ahead: IPO market ramps up with 8 deals despite investor caution

PGNY

Up to eight companies are set to raise $831 million in the week ahead. Florida insurance brokerage BRP Group (BRP) is the largest by deal size, while employee benefits provider Progyny (PGNY) and Chinese...read more